CABG patients With the publication of 2012 CCS Antiplatelet Therapy Guidelines in August 2013, utilization of all available P2Y12 inhibitors decreased by 5.2% ( p =0.05) within the first month but did not demonstrate a significant trend every month thereafter.
← all excerpts
Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018.
2
—
—
The sentences
Clopidogrel utilization showed similar trends, which also failed to reach statistical significance.